NCT04987788

e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy Rates

Completed NA Results posted Last updated 18 June 2024

What this trial tests

NA trial testing Motívate in Colorectal Cancer in 42 participants. Completed in 27 April 2023.

Timeline

19 August 2021

Primary endpoint
27 April 2023

27 April 2023

Quick facts

Lead sponsor	Icahn School of Medicine at Mount Sinai
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	42
Start date	19 August 2021
Primary completion	27 April 2023
Estimated completion	27 April 2023
Sites	1 location across United States

Drugs / interventions tested

• Motívate
• Video link

Conditions studied

• Colorectal Cancer — all drugs for Colorectal Cancer →

Sponsor

Icahn School of Medicine at Mount Sinai

Who can join

Eligibility, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Colonoscopy Completion Primary · Six months after enrollment

Screening colonoscopy completion status in medical charts six months after participants are enrolled in the study.

Group	Value	95% CI
Motívate Group	19
Control Group	19

Sponsor's own description

Among Latinos, a fast growing and underserved population, Colorectal Cancer (CRC) is the third leading cause of cancer death in men and in women. Compared to non-Latino whites, Latinos are less likely to be diagnosed with localized CRC and more likely to be diagnosed with advanced stage disease. Of the recommended CRC screening tests, a colonoscopy allows for both the detection and removal of precancerous and cancerous polyps. Although screening colonoscopies can detect and prevent CRC, more than half of Latinos have not received a screening colonoscopy within the recommended time frame (one screening colonoscopy per ten years).

The purpose of this study is to develop and begin to test an electronically-delivered motivational interviewing progressive web application (e-MI app), called Motívate. The Motívate app will be offered in both English and Spanish to patients who self-identify as Latino/a/x, after they receive a referral for a screening colonoscopy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Current Progress in Clinical Research in Secondary Prevention and Early Detection of Colorectal Cancer.
   Partyka O, Pajewska M, Czerw A, Deptała A, et al · · 2025 · cited 2× · PMID 39941735 · DOI 10.3390/cancers17030367